Skip to content
Open access

Circ_STIL Affects Ferroptosis by Sponging miR-338-3p in Oral Squamous Cell Carcinoma.

Sep 2026 · Journal of Oral Pathology & Medicine · 0 citations · 43 references
Medicine

TL;DR

CircSTIL/miR-338-3p axis plays a key role in the malignant progression of oral squamous cell carcinoma and ferroptosis and GPX4 may function as the key target in this regulatory network.

Abstract

Background

Ferroptosis is pivotal in cancer onset and progression, which can be mediated by non-coding RNAs.

Objectives

This study examined the expression profile of circSTIL/miR-338-3p in oral squamous cell carcinoma (OSCC) patients. Its regulatory mechanism in ferroptosis and OSCC cells was also examined.

Materials And Methods

Fifty OSCC tissue samples were collected to profile gene expression and validate clinical relevance. Functional assays in OSCC cell lines explored how circSTIL and miR-338-3p modulation affect proliferation and migration. Ferroptosis was assessed by quantifying intracellular Fe2+, ROS, and MDA, while ferroptosis-related key proteins' levels were measured via western blot. Potential target genes were predicted via online databases, with their functions and pathways analyzed using GO and KEGG enrichment analysis.

Results

circSTIL was significantly upregulated in OSCC tumor samples, with its expression levels correlated with tumor size, lymph node metastasis status, and histological grade. Knockdown of circSTIL notably impaired the migratory and invasive capacities of OSCC cells, concurrently initiating ferroptotic cell death. Mechanistically, circSTIL functions as a sponge for miR-338-3p. Silencing miR-338-3p partially reversed the role of si-circSTIL against the malignant behavior of tumor cells, with GPX4 as its direct target.

Conclusion

circSTIL/miR-338-3p axis plays a key role in the malignant progression of OSCC and ferroptosis. GPX4 may function as the key target in this regulatory network.

Read PDF

Similar papers

Open access Jan 2026

Inhibition of miR‐301a‐3p Expression Promotes Ferroptosis: A New Target for Ferroptosis Treatment in TNBC

Background The current treatment of triple‐negative breast cancer (TNBC) remains challenging; however, regulating ferroptosis through miRNAs offers new insights for TNBC treatment strategies. Methods Bioinformatics methods were used to screen ferroptosis‐related differentially expressed genes (FRDEGs) in TNBC, and ferr...

Bai-Yang Fu, Yuan Yao, Wenlong Liang et al. · 0 citations
Oct 2026

CircENO1 drives gastric cancer progression via SPI1-mediated transcriptional activation of ENO1.

BACKGROUND Circular RNAs (circRNAs) are critical regulators of tumor biology. However, the role of circENO1 in gastric cancer (GC) remains unclear. This study investigated the biological function and molecular mechanism of circENO1 in GC. METHODS CircENO1 expression was evaluated using a publicly available dataset, c...

Yuan Yuan, Peng Zhang, Yu-Cheng Song · 0 citations
Open access Sep 2026

Mechanism of ZNF154-mediated regulation of ferroptosis in bladder cancer through the PTEN/PI3K/AKT axis

Bladder cancer (BLCA) is one of the most common malignancies of the urinary tract and is characterized by high recurrence and progression rates. Although urinary ZNF154 hypermethylation has been associated with an increased risk of BLCA recurrence, the biological function and molecular mechanism of ZNF154 in BLCA...

Gan Zhang, Xue-Peng Rao, Zhen Song et al. · 0 citations
Sep 2026

KAT2B epigenetically activates GSTZ1 via H3K9ac to suppress proliferation and stemness and enhance ferroptosis in oral squamous cell carcinoma.

It is found that KAT2B transcriptionally activates GSTZ1 in a H3K9ac-dependent manner, which in turn inhibits GPX4 expression, thereby suppressing OSCC proliferation and stemness while enhancing ferroptosis sensitivity.

Tong Sha, Kun Jiao, Jia-Ning Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.